| 000 | 01297 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250511182428.0 | ||
| 264 | 0 | _c19921117 | |
| 008 | 199211s 0 0 eng d | ||
| 022 | _a0167-5699 | ||
| 024 | 7 |
_a10.1016/0167-5699(92)90009-V _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLynn, W A | |
| 245 | 0 | 0 |
_aLipopolysaccharide antagonists. _h[electronic resource] |
| 260 |
_bImmunology today _cJul 1992 |
||
| 300 |
_a271-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAntimicrobial Cationic Peptides |
| 650 | 0 | 4 |
_aBlood Proteins _xpharmacology |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aEndotoxins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipid A _xanalogs & derivatives |
| 650 | 0 | 4 |
_aLipopolysaccharides _xphysiology |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 |
_aPolymyxin B _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Immunologic _xdrug effects |
| 700 | 1 | _aGolenbock, D T | |
| 773 | 0 |
_tImmunology today _gvol. 13 _gno. 7 _gp. 271-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0167-5699(92)90009-V _zAvailable from publisher's website |
| 999 |
_c1395150 _d1395150 |
||